BIG PHARMA SPLIT CL.A
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
BIG PHARMA SPLIT CL.A (XN4) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, BIG PHARMA SPLIT CL.A (XN4) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
BIG PHARMA SPLIT CL.A - Net Assets Trend (None–None)
This chart illustrates how BIG PHARMA SPLIT CL.A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BIG PHARMA SPLIT CL.A (None–None)
The table below shows the annual net assets of BIG PHARMA SPLIT CL.A from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to BIG PHARMA SPLIT CL.A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
BIG PHARMA SPLIT CL.A Competitors by Market Cap
The table below lists competitors of BIG PHARMA SPLIT CL.A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Fonu2 Inc
PINK:FONU
|
$86.42K |
|
Goliath Film and Media Holdings
PINK:GFMH
|
$86.45K |
|
Minapharm Pharmaceuticals
EGX:MIPH
|
$86.50K |
|
SOND6F
SA:SOND6F
|
$86.55K |
|
BROOKDALE SR LIVING
BE:B7S
|
$86.38K |
|
Samurai Capital Corp
V:SSS-P
|
$86.34K |
|
Global Dividend Growth Split Corp Class A
TO:GDV
|
$86.13K |
|
Federal National Mortgage Association Fannie Mae
BE:FNM
|
$86.12K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BIG PHARMA SPLIT CL.A's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares BIG PHARMA SPLIT CL.A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently BIG PHARMA SPLIT CL.A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares BIG PHARMA SPLIT CL.A's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BIG PHARMA SPLIT CL.A (XN4) | €- | N/A | N/A | $86.39K |
| Hanna Capital Corp (04U1) | $-79.29K | 0.00% | 0.00x | $116.52K |
| WESTMINSTER RES (08W) | $4.66 Million | -31.33% | 0.12x | $5.16 Million |
| Axonics Inc (0I3) | $570.14 Million | -10.47% | 0.16x | $3.29 Billion |
| Global Bioenergies SA (1DK) | $14.81 Million | -86.04% | 0.89x | $369.68K |
| GIEAG Immobilien AG (2GI) | $41.80 Million | 40.21% | 8.93x | $15.57K |
| 2invest AG (2INV) | $82.61 Million | -2.29% | 0.06x | $13.67 Million |
| PT Central Proteina Prima Tbk (4PT) | $3.42 Trillion | 11.74% | 1.00x | $6.90 Million |
| DGH Deutsche Grundwert Holding AG (5TR) | $0.00 | 0.00% | 0.00x | $18.45K |
| SOFTCHOICE CORP. (90Q) | $58.23 Million | -19.76% | 10.01x | $470.36 Million |
| ALBA SE (ABA) | $142.95 Million | 5.25% | 0.45x | $5.10 Million |